Whoops! … may contain a carcinogen –
July 9, 2020 – Two more pharmaceutical companies have issued a recall for a medication used to control high blood sugar in people with Type 2 diabetes because it may contain a carcinogen.
Lupin Pharmaceuticals Inc. issued the recall for all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500 mg and 1000 mg because “additional analysis revealed that certain tested batches were above the Acceptable Daily Intake Limit for the impurity N-Nitrosodimethylamine (NDMA),” according to a statement posted by the U.S. Food and Drug Administration.
